Inspire Investing LLC Purchases 303 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Inspire Investing LLC grew its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 13.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 2,601 shares of the medical instruments supplier’s stock after buying an additional 303 shares during the quarter. Inspire Investing LLC’s holdings in ICU Medical were worth $404,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently modified their holdings of ICUI. Diversified Trust Co increased its position in ICU Medical by 32.3% during the fourth quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier’s stock worth $512,000 after acquiring an additional 805 shares during the period. Principal Financial Group Inc. grew its position in shares of ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after purchasing an additional 25,031 shares in the last quarter. Franklin Resources Inc. raised its position in shares of ICU Medical by 99.3% in the third quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier’s stock valued at $2,111,000 after buying an additional 5,834 shares in the last quarter. Coldstream Capital Management Inc. bought a new stake in shares of ICU Medical in the third quarter valued at approximately $227,000. Finally, Geode Capital Management LLC grew its position in ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after buying an additional 48,106 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insider Activity at ICU Medical

In other news, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the sale, the director now directly owns 5,037 shares of the company’s stock, valued at approximately $796,400.07. This trade represents a 16.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Christian B. Voigtlander sold 1,962 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The disclosure for this sale can be found here. In the last three months, insiders have sold 29,737 shares of company stock valued at $4,941,832. 6.70% of the stock is owned by insiders.

ICU Medical Stock Performance

ICU Medical stock opened at $172.30 on Friday. The stock has a market cap of $4.22 billion, a PE ratio of -37.70 and a beta of 0.63. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 12-month low of $86.80 and a 12-month high of $196.26. The business’s 50-day moving average price is $161.06 and its two-hundred day moving average price is $160.84.

Wall Street Analysts Forecast Growth

ICUI has been the subject of several analyst reports. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, December 11th. KeyCorp upped their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. Finally, StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.